0
     

Report Added
Report already added
Dermatologicals in China

Dermatologicals in China

Dermatologicals saw only a mild negative impact from the COVID-19 pandemic in 2020, maintaining a slight positive trend, albeit seeing a slight slowdown in its growth rate. Therefore, a small-scale rebound in the growth rate is expected in 2021, mainly thanks to the recovery of traffic to offline chemists/pharmacies. However, the performance varies between different categories. Topical antifungals is set to see higher growth, since home seclusion significantly reduced the incidence of tinea pedi...

Euromonitor International's Dermatologicals in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Dermatologicals in China

DERMATOLOGICALS IN CHINA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Dermatologicals shows resilience and sustains healthy growth
Haemorrhoid treatments bucks the trend during the pandemic
PROSPECTS AND OPPORTUNITIES
Hair loss treatments buoyed by e-commerce sales
Dermatologicals still dominated by non-herbal products
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2016-2021
Table 2 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 4 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 6 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN CHINA
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 9 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2016-2021
Table 11 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 12 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 13 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Report Title: Dermatologicals in China


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW